30 ROCKEFELLER PLAZA,                                    
NEW YORK , NY, 10112
    
                            NEW YORK , NY, 10112
Summary
The fund seeks capital appreciation in the long term by investing in companies across any size outside the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team focuses on securities of non-US companies that are estimated to trade below their fai More
Link
Directors
Mar 5, 2024- Robert M. Solmson
 - Kenneth S. Davidson
 - Trevor W. Morrison
 - Evan L. Russo
 - Franci J. Blassberg
 - Richard Reiss, Jr.
 - Nancy A. Eckl
 - Nathan A. Paul
 
Chief Compliance Officer
- Nargis Hilal
 
Fund Manager(s)
- John Reinsberg
 - Mark Little
 - Michael Bennett
 - Robin Jones
 - Jimmie Bork
 
Price
- 52-Week High/Low
 - $16.94 - $12.77
 
- Turnover
 - 32.3%
 
- Expense Ratio
 - 0.81%
 
                                                Company Name | 
                                            
                                                Holding | 
                                        
| Novo Nordisk A/S | 5.46 % | 
| ASML Holding NV | 4.32 % | 
| RELX PLC | 3.3 % | 
| ICON PLC | 2.81 % | 
| Siemens AG | 2.44 % | 
| Aon PLC | 2.36 % | 
| Coca-Cola Europacific Partners PLC | 2.32 % | 
| ABB Ltd | 2.2 % | 
| Accenture PLC | 2.16 % | 
| Airbus SE | 2.11 % | 
| More | 2.11 % | 
Documents
Performance
YTD
-
3 Year
5.9%
5 Year
-11.47%
Best
27.87%
                                            2017
                                        
                                    Worst
-39.98%
                                            2008
                                        
                                    | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | 5.8% | 7.8% | -8.4% | -5.7% | -23.8% | 11.5% | 2.3% | 5.7% | -0.3% | 
| Q2 | - | -4.5% | 3.9% | -11.7% | 14% | 16% | 2.7% | -0.5% | 7.8% | -1.3% | 
| Q3 | - | - | -6.7% | -10.2% | -8.8% | 5.6% | -2.3% | 2.3% | 5.7% | 2.2% | 
| Q4 | - | - | 11.8% | 12.9% | -0.7% | 17.2% | 5.1% | -11.8% | 6.1% | -5.7% | 
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - | 
| 2024 | -0.8% | 4.5% | 2% | -3.9% | - | - | - | - | - | - | - | - | 
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 2% | 15% | -18% | -3% | 9% | 19% | -11% | 28% | -5% | 
Alpha
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LISIX | - | 2% | 15% | -18% | -3% | 9% | 19% | -11% | 28% | -5% | 
| S&P 500 | - | - | - | -21% | 27% | 16% | 29% | -6% | 19% | 10% | 
| Alpha | - | 2% | 15% | 3% | -30% | -7% | -10% | -4% | 8% | -15% |